Dianthus Therapeutics Stock Volatility
| DNTH Stock | 23.99 0.16 0.67% |
Dianthus Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0386, which denotes the company had a -0.0386% return per unit of standard deviation over the last 3 months. Dianthus Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Dianthus Therapeutics' Standard Deviation of 3.83, coefficient of variation of (2,096), and Mean Deviation of 2.81 to check the risk estimate we provide. Key indicators related to Dianthus Therapeutics' volatility include:
360 Days Market Risk | Chance Of Distress | 360 Days Economic Sensitivity |
Dianthus Therapeutics Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Dianthus daily returns, and it is calculated using variance and standard deviation. We also use Dianthus's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Dianthus Therapeutics volatility.
Dianthus |
ESG Sustainability
While most ESG disclosures are voluntary, Dianthus Therapeutics' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Dianthus Therapeutics' managers and investors.Environmental | Governance | Social |
Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of Dianthus Therapeutics at lower prices. For example, an investor can purchase Dianthus stock that has halved in price over a short period. This will lower their average cost per share, thereby improving the overall portfolio performance when market normalizes.
Moving against Dianthus Stock
| 0.61 | VTRS | Viatris | PairCorr |
| 0.53 | BMY | Bristol Myers Squibb Sell-off Trend | PairCorr |
| 0.51 | ESPR | Esperion Therapeutics Buyout Trend | PairCorr |
Dianthus Therapeutics Market Sensitivity And Downside Risk
Dianthus Therapeutics' beta coefficient measures the volatility of Dianthus stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Dianthus stock's returns against your selected market. In other words, Dianthus Therapeutics's beta of 1.58 provides an investor with an approximation of how much risk Dianthus Therapeutics stock can potentially add to one of your existing portfolios. Dianthus Therapeutics exhibits very low volatility with skewness of 0.1 and kurtosis of 0.54. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Dianthus Therapeutics' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Dianthus Therapeutics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.
3 Months Beta |Analyze Dianthus Therapeutics Demand TrendCheck current 90 days Dianthus Therapeutics correlation with market (Dow Jones Industrial)Dianthus Beta |
Dianthus standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.
Standard Deviation | 3.85 |
It is essential to understand the difference between upside risk (as represented by Dianthus Therapeutics's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Dianthus Therapeutics' daily returns or price. Since the actual investment returns on holding a position in dianthus stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Dianthus Therapeutics.
Dianthus Therapeutics Stock Volatility Analysis
Volatility refers to the frequency at which Dianthus Therapeutics stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Dianthus Therapeutics' price changes. Investors will then calculate the volatility of Dianthus Therapeutics' stock to predict their future moves. A stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Dianthus Therapeutics' volatility:
Historical Volatility
This type of stock volatility measures Dianthus Therapeutics' fluctuations based on previous trends. It's commonly used to predict Dianthus Therapeutics' future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.Implied Volatility
This type of volatility provides a positive outlook on future price fluctuations for Dianthus Therapeutics' current market price. This means that the stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Dianthus Therapeutics' to be redeemed at a future date.Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Dianthus Therapeutics Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.
Dianthus Therapeutics Projected Return Density Against Market
Given the investment horizon of 90 days the stock has the beta coefficient of 1.5838 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Dianthus Therapeutics will likely underperform.Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Dianthus Therapeutics or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Dianthus Therapeutics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Dianthus stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Dianthus Therapeutics has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Predicted Return Density |
| Returns |
What Drives a Dianthus Therapeutics Price Volatility?
Several factors can influence a stock's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.Dianthus Therapeutics Stock Risk Measures
Given the investment horizon of 90 days the coefficient of variation of Dianthus Therapeutics is -2593.23. The daily returns are distributed with a variance of 14.83 and standard deviation of 3.85. The mean deviation of Dianthus Therapeutics is currently at 2.8. For similar time horizon, the selected benchmark (Dow Jones Industrial) has volatility of 0.76
α | Alpha over Dow Jones | -0.39 | |
β | Beta against Dow Jones | 1.58 | |
σ | Overall volatility | 3.85 | |
Ir | Information ratio | -0.08 |
Dianthus Therapeutics Stock Return Volatility
Dianthus Therapeutics historical daily return volatility represents how much of Dianthus Therapeutics stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The firm inherits 3.8512% risk (volatility on return distribution) over the 90 days horizon. By contrast, Dow Jones Industrial accepts 0.7444% volatility on return distribution over the 90 days horizon. Performance |
| Timeline |
About Dianthus Therapeutics Volatility
Volatility is a rate at which the price of Dianthus Therapeutics or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Dianthus Therapeutics may increase or decrease. In other words, similar to Dianthus's beta indicator, it measures the risk of Dianthus Therapeutics and helps estimate the fluctuations that may happen in a short period of time. So if prices of Dianthus Therapeutics fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.| Last Reported | Projected for Next Year | ||
| Selling And Marketing Expenses | 408.2 K | 443.3 K | |
| Market Cap | 53.6 M | 50.9 M |
Dianthus Therapeutics' stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on Dianthus Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much Dianthus Therapeutics' price varies over time.
3 ways to utilize Dianthus Therapeutics' volatility to invest better
Higher Dianthus Therapeutics' stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of Dianthus Therapeutics stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. Dianthus Therapeutics stock volatility can provide helpful information for making investment decisions in the following ways:- Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of Dianthus Therapeutics investment. A higher volatility means higher risk and potentially larger changes in value.
- Identifying Opportunities: High volatility in Dianthus Therapeutics' stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
- Diversification: Understanding how the volatility of Dianthus Therapeutics' stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Dianthus Therapeutics Investment Opportunity
Dianthus Therapeutics has a volatility of 3.85 and is 5.2 times more volatile than Dow Jones Industrial. 34 percent of all equities and portfolios are less risky than Dianthus Therapeutics. You can use Dianthus Therapeutics to enhance the returns of your portfolios. The stock experiences a moderate upward volatility. Check odds of Dianthus Therapeutics to be traded at 26.39 in 90 days.Weak diversification
The correlation between Dianthus Therapeutics and DJI is 0.32 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Dianthus Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
Dianthus Therapeutics Additional Risk Indicators
The analysis of Dianthus Therapeutics' secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Dianthus Therapeutics' investment and either accepting that risk or mitigating it. Along with some common measures of Dianthus Therapeutics stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Risk Adjusted Performance | (0.03) | |||
| Market Risk Adjusted Performance | (0.11) | |||
| Mean Deviation | 2.81 | |||
| Coefficient Of Variation | (2,096) | |||
| Standard Deviation | 3.83 | |||
| Variance | 14.65 | |||
| Information Ratio | (0.08) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Dianthus Therapeutics Suggested Diversification Pairs
Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Dianthus Therapeutics as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Dianthus Therapeutics' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Dianthus Therapeutics' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Dianthus Therapeutics.
Complementary Tools for Dianthus Stock analysis
When running Dianthus Therapeutics' price analysis, check to measure Dianthus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dianthus Therapeutics is operating at the current time. Most of Dianthus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Dianthus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dianthus Therapeutics' price. Additionally, you may evaluate how the addition of Dianthus Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |